Australian researchers have developed a cuttingedge AIpowered tool that could transform type 1 diabetes (T1D) diagnosis and treatment. The tool, pioneered by Western Sydney University, leverages microRNAbased risk scoring to predict T1D progression and treatment responses, offering realtime insights into disease management.
Key Highlights:
-
Dynamic Risk Score (DRS4C): The AI tool uses microRNAs from blood samples to classify individuals as having or not having T1D, enabling early intervention.
-
Predictive Power: Just one hour after therapy, the risk score can determine whether a patient will remain insulinfree, improving treatment precision.
-
Global Validation: The model was developed using 5,983 study samples from India, Australia, Canada, Denmark, Hong Kong, New Zealand, and the US, and validated in 662 additional participants.
-
Beyond Diagnosis: The tool can differentiate T1D from type 2 diabetes, addressing misdiagnosis concerns and refining personalized treatment strategies.
-
Future Potential: Researchers believe this AIdriven approach could extend to other diseases, offering adaptive monitoring without stigma
With AI reshaping healthcare, this breakthrough promises timely, personalized diabetes management, setting a new standard in precision medicine.
Sources: Nagaland Post, MSN, Ahmedabad Mirror